Key Issues Dialogue: von Willebrand Disease

About the Participants

Dr. Alan Kinniburgh is Chief Executive Officer of the National Hemophilia Foundation. Since assuming this position in 2005, he has strengthened the nonprofit organization in a variety of ways. One early initiative was establishing the NHF's Department of Public Policy. The department focuses on state and federal issues that are important to the bleeding disorders community, such as lifetime insurance caps and Medicare co-payments. Prior to joining NHF, Dr. Kinniburgh was Senior Vice President of Research at The Leukemia & Lymphoma Society. Dr. Kinniburgh also worked as a cancer researcher at Roswell Park Cancer Institute in Buffalo, N.Y., where he founded the Institute's Laboratory of Molecular Diagnostics

Dr. Andra James is a maternal-fetal medicine specialist and an Assistant Professor in the Department of Obstetrics and Gynecology at the Duke University Medical Center. She is a Co-Director of Duke's Comprehensive Hemostasis and Thrombosis Center and founder of the Women's Hemostasis and Thrombosis Clinic at Duke. Her practice, research and publications pertain to reproductive issues among women with hematologic disorders. Besides her work at Duke, she is involved nationally and internationally in activities to improve maternal and fetal outcomes of pregnancy in women with hematologic disorders. She is a Co-Chair of the Women's Issues Scientific Subcommittee of the International Society on Haemostasis and Thrombosis, serves on the Medical and Scientific Advisory Committee of the National Hemophilia Foundation (NHF), chairs the Women with Bleeding Disorders Task Force of the NHF, participates in the Coalition to Prevent Deep Vein Thrombosis, serves on the von Willebrand Disease medical advisory committee of ZLB Behring, recently served on the NIH National Heart Lung and Blood Institute's Women with Bleeding Disorders Working Group and continues to serve on their von Willebrand Disease Expert Panel.

Paul R. Perreault is Executive Vice President of Worldwide Commercial Operations at ZLB Behring. With more than 25 years of healthcare industry experience, Mr. Perreault is responsible for all sales, marketing and commercial development activities for the company. Prior to joining ZLB Behring, he was Vice President and General Manager of Plasma Operations at Aventis Bio-Services, where he oversaw all plasma operations and compliance initiatives at 79 plasma collection centers in the United States. He previously worked for Wyeth-Ayerst Laboratories for 16 years in various key positions.